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Colony stimulating factor in the induction of lupus nephritis. In this
study we examine the role of colony stimulating factor-i (CSF-1) in the
induction of lupus nephritis. The purpose of the study was to establish
the relationship of CSF-1 to the prominent influx of macrophages (MØ)
in the glomeruli of MRL-lpr mice with autoimmune lupus nephritis. The
kidneys of MRL-lpr mice were examined before (<12 weeks of age) and
after (>12 weeks of age) renal injury for CSF-1 transcripts by in situ
hybridization. CSF-l mRNA was detected at four weeks of age within
glomeruli and increased with disease severity. To examine whether
glomerular MØ (glom MØ) required CSF-1 we isolated MØ from the
kidneys of MRL-lpr mice. Two types of glom MØ (with morphological
and growth characteristics which correlated with the presence or
absence of proteinuria) were isolated. Under CSF-l-free culture condi-
tions, where the viability of glom MØ from proteinuric mice was
maintained, glom MØ from pre-proteinuric mice were unable to survive.
Neutralization of CSF- I in the media reduced viability of pre-protein-
uric glom MØ (5 to 6 x), while viability of proteinuric glom MØ was
diminished < 1.5 x. Additionally, CSF-l supplementation induced a 10
x proliferation of pre-proteinuric glom MØ when compared to CSF-l-
free medium. In contrast, proteinuric glom MØ did not proliferate in
response to CSF-l. These studies suggest that CSF-1 induces macro-
phage proliferation and differentiation within glomeruli and, in turn,
renal injury.
Spontaneous autoimmune renal injury in MRL-lpr mice
shares many of the characteristics of human lupus nephritis [1].
Kidney disease in this strain is rapid, predictable and lethal.
Glomerular dysfunction, as reflected by proteinuria, starts at
about three to four months of age, and a 50% mean survival for
these mice is five to six months of age [1]. The earliest renal
histopathology is the perivascular infiltration of lymphocytes
and monocytes readily detected by two months of age. One
month later, there is a notable increase in cellularity composed
of mesangial cells and macrophages (MØ) within the intraglo-
merular mesangial area. The accumulation of MØ in the mes-
angium is abnormal since these cells are only occasionally
detected in glomeruli of normal mice [2, 3]. The molecules
responsible for MØ recruitment and sustained survival in gb-
meruli are not known. There is compelling evidence mitigating
against either complement activation or immune complex dep-
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osition as principal mechanisms underlying monocyte invasion
in glomerulonephritis [reviewed in 3]. Whatever the mechanism
responsible for the recruitment of MØ, these cells are activated
as reflected by enhanced expression of Ia, and have the
capacity to induce tissue destruction as reflected by increased
generation of reactive oxygen intermediates and enhanced
production of proinflammatory eicosanoids [4-6].
In view of the intraglomerular prominence of MØ in murine
lupus nephritis, recent work in our laboratory has focused on
the potentially pathogenic importance of C SF-i. This factor
regulates MØ growth, differentiation and survival [7] and is a
potent chemoattractant [8]. We and others have detected ele-
vated levels of CSF. 1 in the circulation of MRL-lpr mice [9, 10].
An implicating role for CSF- 1 in lupus nephritis is suggested by
enhanced expression of mRNA for CSF-l in kidney cortices of
MRL-lpr mice from two months of age, prior to the onset of
proteinuria [9]. Furthermore, IL-i and TNF, cytokines ex-
pressed in the kidneys of MRL-lpr mice with nephritis [11, 12],
induce CSF.1 [13, 14]. Finally, several intrarenal cell types,
including mesangial cells, endothelial cells and fibroblasts,
which are thought to participate in the pathogenesis of renal
injury, produce CSF-1 [14-18].
In the present study, we have further dissected out the
pathogenic role of CSF-l in MRL-lpr lupus nephritis, with
particular emphasis on the relationship of this growth factor to
glomerular macrophages (glom MØ). By in situ hybridization,
our studies identify the glomeruli as the predominant source of
renal CSF- 1. Enhanced CSF- 1 is localized to the mesangiurn at
the same time MØ begin to be increasing well in advance of
overt renal injury. We have isolated pure populations of gb-
merular MØ in culture. Of particular interest, there are two
different types of MØ which can be categorized based on the
stage of disease progression. Glomerular (Glom) MØ cultured
from pre-proteinuric mice require CSF- 1 for both survival and
proliferation, while MØ isolated from glomeruli of mice with
proteinuria (and thus, more advanced nephritis) have a compar-
atively reduced proliferative capacity and survive in the ab-
sence of this growth factor. We propose that, early in the course
of nephritis, intraglomerular CSF-1 creates the necessary envi-
ronment for MØ recruitment and subsequent survival and
maturation within gbomeruli. These glom MØ are then perfectly
situated to participate in mediating glomerular renal injury.
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Methods
Mice
Autoimmune MRL/MpJ-lpr/lpr (MRL-/pr) (H-2') and normal
C3H/FeJ (H2k) mice were obtained from the Jackson Labora-
tory (Bar Harbor, Maine, USA). In addition, both strains were
bred in our facility to provide animals under weaning age. All
mice were maintained in our virus-free facility on standard
laboratory chow. Only female mice were used in all experi-
ments to control for variation between sexes.
Reagents
Tissue culture media and reagents were from Grand Island
Biological Company (GIBCO, Grand Island, New York, USA),
while the fetal calf serum (FCS) used was bought from Hyclone
Laboratories (Logan, Utah, USA). Chemicals were purchased
from Sigma (St. Louis, Missouri, USA) unless otherwise indi-
cated. Monoclonal antibodies (mAb) for IAk (clone 10-2.16),
F4180 antigen and Mac-i (clone M1170.15.11.5.HL) were ob-
tained from American Tissue Culture Collection (ATCC) and
purified by affinity chromatography of supernatants over Pro-
tein A-Sepharose CL-4B columns (Pharmacia, Piscataway,
New Jersey, USA). Polyclonal goat anti-mouse CSF-l and
anti-KLH mAb were provided by Dr. S. Vogel (Uniform
Services Medical School, Bethesda, Maryland, USA). CSF-1
was derived from the supernatants of confluent L929 fibro-
blasts, obtained from ATCC. Mesangial cell supernatants were
obtained from previously isolated and characterized mesangial
cells, as described [18, 191.
Tissue processing
Anesthetized MRL-lpr and C3H!FeJ mice were perfused
through a 25 gauge butterfly needle cannulated into the left
ventricle. Perfusion was undertaken with heparinized Hanks
Buffered Salt Solution (HBSS) while simultaneously transecting
the inferior vena cava above the level of the hepatic vein.
Perfusion was continued until the animal was deemed exsan-
guinated as determined by grayish white coloration of the
abdominal viscera, including the kidneys. Kidneys were then
removed and cut into 3 to 4 mm blocks. Blocks selected for in
situ hybridization were then placed in 4% paraformaldehyde in
phosphate buffered saline (PBS) in diethyl pyrocarbonate-
treated distilled water (DEPC D!W) at 4°C for two hours.
Thereafter, blocks were transferred into 30% sucrose in PBS!
DEPC D/W for 12 to 16 hours overnight at 4°C, following which
they were snap frozen in OCT (Miles Scientific, Naperville,
Illinois, USA) and stored at —70°C. In contrast, tissue for
immunoperoxidase was not fixed but directly snap frozen in
PBS and stored at —70°C. Kidneys were obtained from MRL-
lpr and C3H!FeJ mice between four weeks and five months of
age.
In situ hybridization
To synthesize riboprobes, a 533 bp BamHl/Hind III mouse
CSF-l eDNA fragment (CSF-l cDNA probe provided by Dr.
Steven Clarke, Genetics Institute, Cambridge, Massachusetts,
USA) was subcloned into a PGEM vector (Stratagene, La Jolla,
California, USA), allowing the generation of both sense and
antisense RNA probes, The subsequent hybridization was a
modification of our previously described technique [20]. Four
micrometer thick sections were cut onto 0.05% poly L-lysine
coated slides. Sections were denatured with 20 jig/mI Protein-
ase K (Boehringer Mannheim, Indianapolis, Indiana, USA) in
PBS for 10 minutes and the reaction stopped by immersion in
glycine 2 mg!ml for 30 seconds. Slides were then post-fixed in
4% paraformaldehyde in PBS for 10 minutes and thereafter
treated with triethanolamine acetate, pH 8 and acetic anhydride
for 10 minutes. After a further wash in 2 x SSC, the slides were
dehydrated through graded alcohol baths and air dried. A
hybridization solution containing the 35S-rUTP (Amersham)-
labeled probe (at 5 x i05 cpm/section), 10% dextran sulfate,
0.24 M NaCl, 4 mrs Tris-Cl, pH 7.5, 0.8 mrvi EDTA, 0.4 X
Denhardt's, 200 jig!ml yeast tRNA, 40% formamide and 50 mM
dithiothreiotol (DTT), was added to each section. Sections were
then covered by paraffin and incubated at 50°C overnight. The
parafilm was then removed and the unhybridized probe washed
from the slides at 50°C in two high stringency baths for 20
minutes each, and subsequently at 37°C in progressively lower
stringency SSC/formamidelDTT washes. After digestion with
RNAse, slides were dehydrated in alcohol, air dried and coated
with NTB 2 emulsion (Kodak). After a 7 to 10 day exposure in
the dark at 4°C, autoradiographs were developed in Kodak D19
developer and counterstained with hematoxylin and eosin.
Silver grain counts were graded according to their density on a
scale of 0 to 3 where grade 0 reflected no increase over
background and 3 represented the maximal number of counts.
Immunoperoxidase and immunofluorescence staining
Sections (4 tim) were cut from specimens prepared as de-
scribed above and fixed briefly in acetone. Immunoperoxidase
staining was carried out by the avidin-biotin complex method
[21]. Use of this technique by this laboratory has been de-
scribed elsewhere previously [22, 23]. Briefly, fixed sections
were blocked with 5% horse serum in 50 mM Tris buffer (pH
7.6). Sections were then incubated with diluted F4!80 mAb for
two hours at room temperature in a moist chamber, washed in
Tris buffer and then incubated with biotinylatd mouse absorbed
anti-rat Ig for 60 minutes. This was followed by a 60 minute
incubation with the avidin-biotin-horseradish peroxidase com-
plex (Vectastain ABC reagent, Vector Laboratories, Burlin-
game, California, USA). Peroxidase activity was detected by a
five minute incubation with 3,3' diaminobenzidine 0.5 mg!ml
containing 0.03% H202. Sections were then rinsed and coun-
terstained with methyl-green!alcian blue. Controls included
omission of the primary Ab, and staining with irrelevant anti-
bodies. Sections were graded from 0 to 3 according to the
intensity of staining where a negative result was scored at 0 and
the most strongly positive graded as 3. To detect immune
complex deposition in renal tissue, direct immunofluorescence
studies were performed as previously described [24]. Fluores-
cein-conjugated affinity purified goat anti-mouse IgG F(ab')2
and goat anti-mouse 1gM (mu chain specific, both from Cappel
Research Products, Durham, North Carolina, USA) were used
for immunofluorescence.
Glomerular MØ isolation
Under aseptic conditions glom MØ were isolated from MRL-
lpr female mice  three months. Anesthetized mice were
perfused as described above, to deplete kidneys of potentially
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contaminating passenger monocytes, In each preparation, kid-
ney cortices from four to eight mice were carefully cut away
and minced into small pieces. Using a plunger from a 10 ml
syringe, these pieces were then passed through a series of steel
sieves (250, 150 and 75 pm, W.S. Tyler, Inc., Mentor, Ohio,
USA), with glomeruli being retained in the final sieve. A
glomeruli-enriched preparation of about 85% purity was washed
off and then treated with class 2 collagenase (Worthington
Chemicals, Freehold, New Jersey, USA) 1 mg/mi for 30 min-
utes at 37°C, followed by trypsin/EDTA (0.05%) for a further 10
minutes at 37°C. They were thereafter washed twice in Ca-
and Mg-free HBSS and then plated onto 100 x 15 mm
sterilized bacteriologic plastic dishes (Fisher Scientific Co.,
Pittsburgh, Pennsylvania, USA). Following complete glomeru-
lar dispersion, pure glom MØ could be isolated on the basis of
their ability to attach to bacteriologic plastic. Complete disper-
sion of all glomeruli with removal of cellular debris required
four to five days, leaving a monolayer of adherent cells. Despite
numerous (>4) attempts, glom MØ could not be isolated from
normal C3H/FeJ mice of various ages. MØ culture medium was
composed of R1'MI 1640, 10% heat inactivated FCS, 15% crude
CSF-1 derived from L929 cell supernatant, 1% penicillin-strep-
tomycin and 2 mrvt L-glutamine. L929 fibroblasts, used as the
source of crude CSF-1, were grown to confluence in RMPI
1640, 10% heat inactivated FCS and 1% penicillin-streptomy-
cm. The culture supernatant was removed alter five days,
centrifuged (300 x g, 10 mm), filter sterilized and then stored at
—20°C until further use. Adherent MØ could easily be detached
from bacteriologic plastic by incubation for 20 minutes at 37°C
with a mixture of Ca- and Mg-free HBSS [25].
Isolation of resident peritoneal MØ (RPMØ)
RPMØ were obtained from MRL-lpr and C3H/FeJ mice by
peritoneal lavage of sacrificed animals with 10 ml ice coldCa - and Mg-free HBSS containing 20 U/ml heparin. After
washing with HBSS, cells were resuspended in MØ culture
medium and plated in 100 x 15 mm diameter Petri dishes. After
two hours incubation at 37°C in 7% C02, cells were again
washed to remove non-adherent cells and replenished with
culture medium.
Flow cytometric analysis
Detached cells were stained for F4/80 Ag, Mac-i and MHC
Class II (lak), as previously described [18, 201 and later ana-
lyzed on an Epics C Celisorter (Coulter Electronics, Hialeah,
Florida, USA). Controls included cells without primary Ab or
an isotype matched irrelevant primary Ab (Lyt 2) (Becton
Dickinson, La Jolla, California, USA).
Phagocytosis assay
After an overnight adherence to glass cover slips, MØ were
resuspended in 0.5 ml RPMI. A total of 0.1 ml sheep erythro-
cytes (E), coated with a subagglutinating amount of anti-E IgG
were added to each well and incubated at 37°C for 45 minutes.
Some coverslips were then fixed (with 0.125% glutaraldehyde in
PBS), stained with Giemsa stain and mounted on glass slides
with Permount. Cells were then evaluated for rosettes. The
remaining coverslips were treated with 1/5 x PBS in D/W to
lyse all bound E. After fixing, staining and mounting, cells were
evaluated for ingested E. To control for E binding to non-Fc
receptor surface molecules, non-sensitized E were added to
some wells.
MØ viability
Glom MØ viability was evaluated by 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MIT) assay, according
to the method of Mosmann [261, Detached MØ were re-plated in
96 well plates at a concentration of 3 to 4 x i04 cells/well. Cells
were either incubated in MØ culture medium (enhanced by L929
derived CSF-l) or RPMI containing 15% FCS (and no CSF-1).
CSF- 1 specificity was assessed by incubation with polyclonal
goat anti-mouse CSF- 1 Ab at a blocking dilution of 1:50. An
irrelevant goat anti-KLH mAb was used as a control Ab.
Viability was determined three and six days after incubation,
when supernatants were removed and 10 .d MTT added to each
well. Following a five hour incubation at 37°C with 5% C02,
formazan crystals were solubilized in 100 d 0.04 M HCI in
isopropanol and the plates read in a microtiter plate reader
(Bio-Rad, Melville, New York, NY, USA) at a dual-wavelength
setting of 570 nm and 630 nm. Viability of RPMØ from MRL-lpr
and C3H/FeJ mice was determined for comparison. At least
triplicate wells were used for all experiments.
MØ proliferation
Detached MØ were plated in 96 well plates at a concentration
of 3 to 4 X iO' cells/well. Cells were again incubated in the
presence of CSF-l enhanced medium or medium plus FCS
alone. After 24 hours of incubation, cells were pulsed with 1
1Ci [3H}-labeled thymidine for a further 24 hours in culture.
Cells were then harvested with a semiautomated cell harvester
(PHD, Cambridge, Massachusetts, USA) and [3H] thymidine
incorporation measured by liquid scintillation counting.
Results
CSF-1 is prominently expressed in glomeruli of pre-
proteinuric MRL-lpr mice
Since we previously reported an age and disease related
increase in CSF-1 mRNA expression in renal cortices of MRL-
lpr mice [91, in situ hybridization was utilized to histologically
identify the cells within the kidney that account for enhanced
levels of this growth factor. Table 1 summarizes the distribution
of this growth factor in sections taken from perfused kidneys of
pre-proteinuric and proteinuric MRL-lpr mice and normal C3H/
FeJ mice of different ages. The earliest expression of mRNA for
CSF-i was detected at four weeks of age before the onset of
autoimmune renal injury. The highest grain counts were within
glomeruli with the most prominent increase in CSF- 1 occurring
between weeks 4 and 6 (Fig. 1). Glomerular CSF-1 RNA
transcripts were expressed throughout the course of renal
disease and increased with age and advancing nephritis. The
contribution of CSF-1 mRNA expression by the perivascular
mononuclear infiltration lagged behind glomerular production
by several weeks and appeared to parallel, rather than precede,
subsequent inflammation (Table 1). Of note, CSF-i RNA tran-
script expression in the remaining renal tissue (tubules and
especially vessels) was comparatively less. Furthermore, kid-
neys from normal C3H/FeJ mice did not produce CSF-1, a
finding in keeping with our previous observation [9]. These
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Fig. 1. Phase contrast micrograph of different populations of MØ from MRL-lpr mice. (A) RPMØ from 3-month-old animals. (B) Smaller, stellate,
proliferative glom MØ from pre-proteinuric animals. (C) Larger, round and non-proliferative glom MØ from proteinuric mice with more advanced
nephritis.
results therefore identify glomeruli as the earliest and most
predominant source of renal CSF-l in MRL-lpr mice.
To determine whether there was any correlation between
intraglomerular immunoglobulin deposition and CSF-1 expres-
sion, we examined kidneys of MRL-lpr and age-matched nor-
mal C3FIfFeJ mice for the presence of IgG and 1gM by direct
immunofluorescence. Similar amounts of TgG and 1gM were
detected exclusively in the glomerular mesangium of pre-
proteinuric MRL-lpr and normal C3H/FeJ mice.
Intrarenal distribution of 410 in MRL-lpr mice
We next determined whether the specific cellular sources of
elevated renal CSF-l were pivotal in the pathogenesis of lupus
nephritis. We sought to correlate the temporal relationship
between the intrarenal production of this growth factor with MØ
influx into pre-nephritic and nephritic kidneys. MØ were iden-
tified by immunoperoxidase staining using mAb to F4/80, a
mouse MØ-specific surface antigen [27]. Table 2 indicates that
MØ were present in the interstitium of normal C3H/FeJ mice, as
previously reported [28]. However, in MRL-/pr mice, there was
an age and disease related increase in MØ within glomeruli, as
well as within the interstitium and in the perivascular infiltrate.
While glomerular MØ were increased from four weeks of age,
the most notable increment in infiltration into glomeruli oc-
curred between six and eight weeks of age. Increases in the
interstitium and perivascular infiltrates were not prominent
until animals were eight weeks old. Of interest, few MØ were
identified in the kidney of an older (16 weeks of age) but
non-nephritic MRL-lpr mouse. This suggests that the numbers
of MØ accumulating in glomeruli and not the age alone of
MRL-lpr mice correlates with the severity of renal injury.
These immunoperoxidase studies in conjunction with the in situ
hybridization data suggest that incrementally enhanced expres-
sion of glomerular CSF-l precedes increasing MØ inifitration
into that location.
Isolation and characterization of glomerular MØ
The correlation between intraglornerular CSF-l production
and MØ infiltration does not elucidate the pathogenic mecha-
nism of CSF-l in lupus nephritis. Glom MØ were therefore
isolated from MRL-Ipr mice to address this issue. Two mor-
phologically distinct adherent cell types were repeatedly (more
than 4 times each) isolated depending on the stage of nephritis
(Fig. 2). One cell type was always isolated from pre-proteinuric
mice (termed prc-proteinuric glom MØ), while the other could
only be captured from proteinuric mice (termed proteinuric
Age
Mice weeks
MRL-lpr 1
N
Table t. Distribution of CSF-l mRNA in the kidney using in situ hybridization
Up"
C3H/FeJ
Perivascular
Glomeruli Vessels Tubules infiltrate
3 1.0 0.3 0 0.3 no infiltrate
4 3 1.0 0.7" 0 0.5 no infiltrate
6 2 1.0 1.8" 0 0.6 0.3
8 4 1.3 1.9" 0.3" 0.9" 1.3
12 2 2.0 19" 04b 0.5 0.9
16 4 3.6 2.1" 04" 07" 1.1
20 3 3.6 30" 05b 11" 2.0
3—4 2 1.0 0 0 0.5 no infiltrate
10—12 2 1.0 0.3 0 0.5 no infiltrate
Each N was done in duplicate. Representative sections are graded from 5 high power fields/slide: grade 0: sparse grains ( background), grade
1: slight increase, grade 2: moderate increase and grade 3: marked increase (in grains over background). Resutts are expressed as mean with all
SCM n 0.4.
"Mean urinary protein measured by Albustix, 1 = 30 mg/dl, 2 = 100 mg/dl, 3 = 300 mg/dl, 4 =  2,000 mg/dl (value  2 indicates pathological
proteinuria)
"P < 0.05 MRL-lpr compared to C3H/FeJ; P values required since analysis was non-parametric
"4
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Table 2. MØ increase in glomeruli of MRL-lpr mice
Mice
Age
weeks N Upa Glomeruli
Interstitium .Penvascular
infiltrateCortical Medullary
MRL-lpr 4
6
8
12
16C
16
20
2
3
4
2
1
3
2
1.0
1.0
1.5
1.8
1.0
3.0
3.8
0.8"
1.0"
1.8"
2.0"
1.0
2.3"
2.5"
0.3
0.8
16"
1,3
1.0
17b
2.0"
0.8
0.8
13"
1.3
1.0
17b
1.7"
no infiltrate
0.8
1.2
1.5
no infiltrate
2.2
2.8
C3H/FeJ 2
12
2
2
1.0
1.0
0
0.3
0.8
0.8
0.8
0.8
no infiltrate
no infiltrate
Immunoperoxidase staining of kidney sections is with F4/80 mAb. Grading is as follows: (0) = negative, (1) = positive, (2) = strongly positive
and (3) = very strongly positive staining for F4/80. Results are expressed as means with all SEM 0.3.
a Urinary protein measured by Albustix, I = 30 mg/dl, 2 = 100 mgldl, 3 = 300 mg/dl, 4 =  2,000 mg/dl (value 2 indicates pathological
proteinuria)
b P < 0.05 MRL-lpr compared to C3H/FeJ, P values required since analysis was non-parametric
C Older mouse, not proteinunc
glom MØ). Pre-proteinuric MØ were uniformly smaller and
stellate in appearance (Fig. 2B), and were able to proliferate.
Moreover, these cells could only be isolated if the culture
medium was enriched with CSF-l supplementation. In contrast,
the morphology of proteinuric glom MØ, isolated from mice
with more advanced nephritis, was substantially larger with a
more rounded appearance (Fig. 2C), and they were less capable
of proliferation than the pre-proteinuric cells. Of note, pre-
proteinuric glom MØ maintained in culture for a few weeks
developed the appearance of proteinuric glom MØ and ceased
proliferation. These adherent cell types were verified as mono-
nuclear phagocytes by virtue of F4/80 surface Ag expression. In
every instance (more than 10 different isolations,) pure MØ
populations were obtained, as reflected by positive F4180 stain-
ing of all cells (Fig. 3). MØ were not contaminated by mesangial
or tubular epithelial cells since these intrinsic renal cell types do
not express F4/80 (data not shown).
Glomerular MØ retain a stable and distinctive phenotype in
culture
To ascertain whether glom MØ retained their phenotypic
properties in vitro, cells were analyzed for the presence of
characteristic cell surface molecules, Mac-i (Complement Re-
ceptor 3, CR3) and Ia, as well as for expression of Fc receptors.
Comparative analysis by flow cytometry was made with RPMØ
from MRL-lpr and normal C3H/FeJ mice (Fig. 4). Mac-l was
highly expressed on all populations evaluated with no differ-
ences between any of the cells or strains. Ia, a marker of
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B MRL'lpr glomerular Mo Fig. 3. Purepopulations of F4/80 positive
1 glom MØ can be isolated from MRL-lprkidneys. Glom MØ were isolated as described
Contro'
J
in Methods. Cells were detached with Ca-
and Mg-free HBSS and stained for the
______________
presence of F4/80 surface Ag. Percentage of
99 _______ positive cells is denoted in the upper right
F4/8o' hand corner of each panel. Background
I fluorescence intensity is marked by the
_____________
cursor. (left) L929 cells; (right) glom MØ.
Representative of at least 8 similar
experiments.
_______
Fig. 4. Glom MØ in culture retain phenotypic
I Control I characteristics. Glom MØ were isolated asdescribed in Methods. Cells were detached
with Ca- and Mg-free HBSS and stained
for the presence of Mac-I and Ia. Percentage
IMAC-li of positive cells is shown in the upper right
hand corner of each panel. Background
fluorescence intensity is marked by the
cursor. (left) L929 cells; (middle) C3H/FeJ
RPMØ; (right) MRL-lpr glom MØ.
Representative of at least 7 similar
experiments.
immunological activation, while expressed at high levels on all
MRL-lpr mononuclear phagocytes evaluated, was only present
on some C3H/FeJ RPMØ (25%). Regardless of the stage of
nephritis, most glom MØ, like RPMØ, expressed Fc receptors
for IgG, as reflected by the percentage of MØ with rosetted IgG
sensitized sheep erythrocytes (RPMØ 90.0 1.4; pre-proteinu-
nc glom MØ 92.3 2.3; proteinuric glom MØ 90.8 1.9).
Functionally, these cells were all capable of a similar degree of
Fc receptor-mediated phagocytosis, as determined by the per-
centage of MØ with ingested sheep erythrocytes (RPMØ 94.5
1.1; pre-proteinuric glom MØ 96.3 3.0; proteinuric glom MØ
98.0 0.7). These experiments therefore demonstrate that pure
MØ populations with distinctive characteristics can be isolated
from glomeruli of nephritis-prone mice at different stages during
the course of disease.
Pre-proteinuric glomerular MØ are dependent on CSF-1 for
viability
Since glom MØ could be isolated in culture, we could now
determine whether CSF-l was a growth factor required for
these two distinct populations. CSF-1 was derived from super-
natants of L929 cells, which produce this growth factor as their
predominant secreted protein (l0— of total protein in condi-
tioned medium) [29]. To elucidate whether CSF-l was required
for viability and proliferation, a goat-anti-mouse CSF-l Ab was
used for neutralization. The optimal concentration of anti-
CSF-l Ab was determined by establishing a dilution range over
which the proliferative response to CSF- 1 of bone marrow-
derived MØ precursors could be neutralized. Complete neutral-
ization occurred over a wide dilution range of Ab concentra-
tions (1:20 to 1:640) and was specific and reproducible at both
days 3 and 6 (data not shown). Based on this, a 1:50 dilution or
greater of anti-CSF-1 Ab was used at each time point in all
further experiments. It is important to note that medium alone
was free of CSF- 1, as determined by colony forming assay (data
not shown).
RPMØ from MRL-lpr and C3H/FeJ mice were again com-
pared to glom MØ. By MTT assay, neither population of RPMØ
was dependent on CSF-1 for survival (Fig. 5). At day 3, there
were no differences in survival within or between either RPMØ
population. However, by day 6 there was a reduction in
viability when comparing serum supplementation alone to sup-
plementation with L929 cell supernatant (P < 0.05). Clearly,
CSF-1 did not account for this difference since incubation with
anti-CSF-1 Ab did not alter viability. On the other hand,
pre-proteinuric glom MØ displayed an essential requirement for
CSF-l for survival (Fig. 6A). This is shown by the neutraliza-
tion of the survival-promoting effects of L929 cell supplemen-
tation following incubation with a 1:50 dilution of anti-CSF-1
Ab. This neutralization caused a five- to sixfold reduction in
viability of pre-proteinunic glom MØ by day 3 (P < 0.01) and a
four- to fivefold reduction at day 6 (P < 0.01). In striking
contrast, proteinunic glom MØ survival was diminished by less
than one-third at either time point following neutralization of
CSF-1 (P < 0.05, Fig. 6B). Moreover, these cells could survive
in CSF-1-free medium alone, unlike pre-proteinuric glom MØ.
Notably, though, pre-proteinuric glom MØ maintained in cul-
ture for a few weeks were, like proteinuric glom MØ, no longer
CSF-l dependent (data not shown).
CSF-1 is required for proliferation of pre-proteinuric glom
MØ
Since the above experiments indicated that pre-proteinuric
glom MØ required CSF-l for survival, we next examined
whether this cytokine induced proliferation of mononuclear
phagocytic cells, as determined by [3H] thymidine incorpora-
tion. While glom MØ failed to proliferate when incubated in
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Fig. 5. CSF-1 is not essential for survival of RPMØ from C3H/FeJ or
MRL-lpr mice. After a 4 to 5 day incubation in CSF-l enriched medium
(15% L929 SN in RPMI + 10% FCS) following isolation, RPMØ from
either (A) C3H/FeJ or (B) MRL-lpr mice were plated in 96 well plates at
3 to 4 x io cells/well. MØ were cultured either with medium and FCS
alone (solid bars), CSF-1 enriched medium (open bars), CSF-l enriched
medium and 1:50 dilution of anti-mouse CSF-l Ab (hatched bars) or
CSF-1 enriched medium and 1:50 control anti-KLH mAb (stippled
bars). Values are means SEM after 3 or 6 further days in culture.
Graphs represent I of 3 reproducible experiments done in triplicate. *P
<0.05 for medium and FCS alone vs. all other culture media.
CSF-1-free medium, L929 cell supplementation induced a ten-
fold proliferation of pre-proteinuric glom MØ (Fig. 7). In con-
trast, proteinuric glom MØ did not proliferate in response to
CSF-1. The viability and proliferation data suggests a differen-
tial requirement for CSF-l by glom MØ, which is dependent
upon the stage of glomerulonephritis at which these cells are
isolated.
Discussion
The mechanisms underlying monocyte migration into glomer-
uli of MRL-lpr mice, and the subsequent survival of these cells
in that location, are not understood. Enhanced CSF-1 produc-
tion in kidneys of autoimmune mice [9, 10] certainly has the
capacity to fulfill these pathogenetic requirements since CSF- 1
is both MØ specific and important for survival, growth, differ-
entiation and chemotaxis of these cells [7]. The in situ hybrid-
ization and immunohistochemical data in this study suggest that
CSF-l and MØ are both detected in the glomerulus of MRL-lpr
mice at four weeks of age, prior to any other evidence of kidney
injury. While the correlation between MØ infiltration and pro-
Fig. 6. Glom MØfrom pre-proteinuric but not proteinuric mice require
CSF-1 for survival. After a 4 to 5-day incubation in CSF-1 enriched
medium (15% L929 SN in RPMI + 10% FCS) following isolation, glom
MØ from either pre-proteinuric (A) or proteinuric mice (B) were plated
in 96 well plates at 3 to 4 x iO cells/well. MØ were cultured either with
medium and FCS alone (solid bars), CSF-1 enriched medium (open
bars), CSF-1 enriched medium and 1:50 or 1:1000 dilution of anti-mouse
CSF-1 Ab (hatched bars) or CSF-l enriched medium and 1:50 control
anti-KLH mAb (stippled bars). Values are means SEM after 3 or 6
further days in culture. Graph (A) represents 1 of 2 and graph (B) 1 of
3 reproducible experiments, each performed in triplicate. < 0.01 vs.
CSF-1 enrichment and vs. CSF-1 and 1:50 dilution of control Ab; l:P <
0.05 vs. CSF-l enrichment; no differences if no symbol.
teinuria is in accordance with other experimental models of
glomerulonephritis [30, 31], these studies are the first to report
that MØ captured from pre-proteinuric mice require CSF-1 for
growth and division, while MØ from proteinuric mice do not
proliferate to CSF-1, nor require this growth factor for viability.
Furthermore, this is the first description of enhanced CSF-l
expression within the glomerulus of pre-proteinuric mice.
Taken together, our data suggest that enhanced CSF-l is
responsible for promoting the accumulation of MØ in the
glomerulus which, in turn, cause renal tissue destruction.
Obviously, unraveling the contribution of CSF-1 to glomeru-
Jar injury in lupus nephritis requires identification of the specific
intraglomerular cellular origin of this growth factor. Although
by in situ hybridization we identified CSF-l transcripts in
glomeruli, technical limitations preclude locating the exact
cellular source. The potential sources could be any of the
different glomerular cellular constituents, including mesangial
and endothelial cells (both known to produce CSF-1) as well as
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Fig. 7. Glom MØ from pre-proteinuric but not proteinuric mice prolif-
erate in response to CSF-1. Isolated glom MØ from either pre-protein-
uric or proteinuric mice were plated in 96 well plates at 3 to 4 >( IO
cells/well. MØ were either cultured with medium and FCS alone (solid
bars) or CSF-l enriched medium (15% L929 SN in RPMI + 10% FCS;
hatched bars) for 24 hours and then pulsed for a further 24 hours with
[3H]-thymidine. *D < 0.01 vs. pre-proteinunc glom MØ cultured in
CSF-l. No differences if no symbol. Graph represents 1 of 2 similar
experiments done in triplicate and quadruplicate.
the less abundant glomerular epithelial cells. However, based
on relatively weak hybridization signals of epithelial cells in
tubules, and endothelial cells in the surrounding medium-sized
vessels, we extrapolate that these cell types do not account for
the bulk of glomerular CSF- 1. By a process of elimination,
mesangial cells, the most prominent cell type within glomeruli,
remain as the likely intrinsic source of this growth factor. This
is supported by our recent observation that cultured MRL-lpr
mesangial cells produce CSF-1 [18]. Enhanced CSF-l expres-
sion by mesangial cells may be a consequence of either a
primary defect in overproduction or a result of dysregulation of
an underlying cytokine cascade, with secondary upregulation of
CSF-l. Studies from our laboratory suggest that mesangial cells
cultured from MRL-/pr mice do not produce more CSF- 1 than
mesangial cells isolated from mice with normal kidneys [18].
Furthermore, our studies have demonstrated that TNF en-
hances CSF-1 production by mesangial cells from MRL-/pr but
not normal mice [18]. Taken together, our data favor the
hypothesis that a dysregulated cytokine cascade causes a
secondary increase in CSF- 1 production and is not related to a
primary defect in the mesangial cell of MRL-lpr mice. This is
further strengthened by the observations that IL-i and TNF,
elevated in glomeruli of mice with lupus nephritis, regulate
CSF-l [13, 14]. Mesangial cells have recently been reported to
increase production of CSF-l following the binding to their Fc
receptors of IgG [321. This raises the possibility that immune
complexes could potentially trigger CSF-l production by mes-
angial cells in lupus nephritis. We therefore examined kidneys
from MRL-/pr mice and detected immune complex deposition
in the mesangium at four weeks of age, the point at which
CSF-i is first expressed. However, since we also observed a
similar finding in glomeruli from age-matched normal C3H!FeJ
mice, this underlying mechanism for enhanced CSF-1 remains
speculative.
Glom MØ are themselves a possible intraglomerular source of
CSF-1. MØ are sparse in glomeruli of normal mice, but are
abundant in glomerulonephritis [3]. Although production of
CSF-1 by circulating human monocytes has previously been
reported [33], we have been unable to detect expression of this
growth factor in either RPMØ or glom MØ (data not shown). The
cellular origin of the subsequent and secondary CSF-1 tran-
script expression within the renal mononuclear infiltrates in
MRL-/pr remains unclear. Known cellular constituents of the
infiltrate include CD4+ and CD8+ T cells (58% and 12%
respectively, of infiltrating mononuclear cells), the unusual
double negative (CD4—, CD8—, B220+, CD3+) T cells (15 to
20%), B cells (5%) and MØ (3%) [34]. The recent report by
Hallet et a! [35] that normal human T cell clones produce CSF-l
strengthens the argument for implicating these cells. To date,
attempts to isolate single positive T cells in culture from
nephritic kidneys have been unsuccessful. However, double
negative kidney-infiltrating T cells, recently cloned from MRL-
lpr kidneys in our laboratory [36], do not produce CSF-l
(unpublished data). We are currently evaluating lymphoid or-
gans from the MRL-lpr strain to establish the contribution to
CSF-1 production from each T cell population.
Perhaps the most intriguing observation is the heterogeneity
of the two glom MØ populations, isolated from different stages
of the pathogenesis of glomerular disease. These two MØ
populations have distinctive morphologic features and growth
requirements. This implies either that infiltrating glom MØ
change their morphology and growth requirements at different
time points in the course of disease, or that glomerulonephritis
is characterized by influx of different MØ populations during
injury. We favor the former possibility. First, we have observed
that maintenance of the small stellate pre-proteinuric glom MØ
in culture for longer time points (4 to 6 weeks) results in their
transition to the morphology of glom MØ from mice with more
advanced nephritis, with a visibly reduced proliferative capac-
ity. Second, pre-proteinuric glom MØ are uniquely dependent
on CSF-l for survival, unlike proteinuric glom MØ and RPMØ.
Finally, pre-proteinuric glom MØ proliferate at a considerably
higher rate than glom MØ from proteinuric mice. These obser-
vations indicate that MØ may have different growth require-
ments and morphologies at different stages of this autoimmune
disease process. They further suggest that pre-proteinuric glom
MØ represent a more immature stage in the differentiation of
recruited mononuclear phagocytic cells. In view of high F4/80
surface Ag expression, pre-proteinuric glom MØ are probably
more mature than circulating monocytes and therefore repre-
sent MØ recently recruited into glomeruli, yet still capable of
CSF-i-dependent growth and proliferation. Since pre-protein-
uric MØ which are recruited to glomeruli have the capacity to
initially divide, their accumulation may reflect local prolifera-
tion in the CSF-l enriched milieu of glomeruli rather than
continued recruitment from the circulation. In contrast, pro-
teinuric glom MØ are terminally differentiated, no longer require
CSF-l for survival and have lost their capacity to multiply.
Experiments are currently in progress to establish the respec-
tive functions and cytokine profiles of these distinct glom MØ.
We speculate that enhanced mesangial CSF-l precedes the
influx of MØ into the glomerulus. In sequential renal sections of
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pre-proteinuric MRL-lpr mice evaluated for CSF-l and MØ,
CSF-l expression was enhanced prior to an increase in MØ.
However, since the techniques of detecting CSF- 1 (in situ
hybridization) and MØ (immunoperoxidase) vary in sensitivity,
we cannot definitely conclude that abnormal CSF-l expression
precedes MØ accumulation. Nevertheless, the requirement of
pre-proteinuric MØ for CSF- 1 for growth and division strongly
suggests that CSF-l would have to be readily produced for MØ
to accumulate in the glomerulus. We are currently evaluating
whether enhanced CSF-i is the chemoattractant required for
MØ influx into glomeruli.
In summary, based on these studies we suggest that pre-
proteinuric glom MØ, dependent on CSF-l, are recruited to
glomeruli. The hypercellularity that results from local MØ
survival and proliferation promotes glomerular damage and
causes proteinuria. Finally, once CSF-1 independent protein-
uric glom MØ lose their proliferative capacity, glomeruli be-
come relatively hypocellular and increasing fibrosis ensues. In
conclusion, this manuscript reports that CSF-l is critical in the
pathogenesis of murine autoimmune renal damage. It is tempt-
ing to speculate that in the absence of glomerular CSF-1
expression, autoimmune renal injury would be thwarted.
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